microchip controlled subcutaneous drug delivery devices   Microchip Controlled Subcutaneous Drug Delivery •  September 2017  •  MCD494K  •  Price US $2,850



As therapeutic drug markets continue to evolve, advancements in drugs and devices are producing several positive improvements. New formulations are extending drug release profiles, leading to less frequent dosing. Enhancements in syringe and injector usability are increasing the number and types of therapeutics that can be self-administered. These advances have revealed a new set of concerns. Weekly, bi-weekly and monthly dosing deprives the patient of the repetitive reinforcement that is a key tenet of self-injection safety at a time when the dangers associated with powerful drug side effects are placing a priority on the need for accurate dosing and delivery. In response, device suppliers have been developing syringes and injectors with new technology, adding capabilities that address self-administration safety concerns. Using innovative technical solutions, these device features decrease patient reliance on recall, guiding them through the medication process and reducing the risk of drug dosing errors.

Bar_Graph Microchip Controlled Drug Delivery Report Brochure (Download PDF)

Blue document Microchip Controlled Drug Delivery Report Order Form (Download PDF)


Microchip Controlled Subcutaneous Drug Delivery Devices – What You Will Learn

• What SC injection devices rely on microprocessors to control the three stages of injection, what are the device specifics, and who markets them?
• What are the essential design factors for microchip controlled subcutaneous injection devices, what are the enabling technologies, and what are the performance criteria?
• What is the size of the market today, who are the market share leaders, and what will the market share be in 2024?
• What are the therapeutic applications for microchip controlled injectors, who are the developers, and what indications are they targeting?
• What are the market drivers for microchip controlled subcutaneous drug delivery devices?
• What are the significant economic, technology, and regulatory factors affecting the market?


Microchip Controlled Subcutaneous Drug Delivery Devices – Summary of Contents

Executive Summary

Microchip Controlled Drug Delivery

Devices and Technologies

Market Segments and Indications

Demographics and Growth

Market Drivers

Risk Factors

 

Microchip Injection Device Design Factors

Chip Technology

Sensors

Data Collection & Transfer

Communication

Data Interface

 

Microchip Controlled Injector Features & Capabilities

Authentication

EMR Integration

Injection Event Time Stamp

Needle Injection Depth & Speed

Power Management

Remote Monitoring

Variable Dose Capture

Wireless Data Transfer

 

Microchip Controlled Injection Device Commercial Analysis

Handheld Devices

Autoinjectors

Single Use

Multi-use

Needle-free Injectors

Pen Injectors

Wearable Devices

Development-stage Devices

 

Microchip Device Therapeutics, Applications & Market Data

Autoimmune Diseases

Biologicals

Antibodies

Immunotherapeutics

Cardiovascular

Metabolic Diseases

Hematology

 

Company Profiles